Clinical Trial Update: Circulating and Urinary Exosomal miRNA as Predictors of Treatment Response in Advanced Kidney Cancer [NA]

View source ↗

Summary

A completed clinical trial evaluates circulating and urinary exosomal microRNA as predictors of treatment response in advanced renal cell carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Snippet

Sponsor: Institute of Oncology Ljubljana | Conditions: Renal Cell Carcinoma | NA | Status: COMPLETED